High-resolution melting (HRM) re-analysis of a polyposis patients cohort reveals previously undetected heterozygous and mosaic APC gene mutations.

Fam Cancer 2015 Jun;14(2):247-57

Department of Clinical Genetics, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.

Familial adenomatous polyposis is most frequently caused by pathogenic variants in either the APC gene or the MUTYH gene. The detection rate of pathogenic variants depends on the severity of the phenotype and sensitivity of the screening method, including sensitivity for mosaic variants. For 171 patients with multiple colorectal polyps without previously detectable pathogenic variant, APC was reanalyzed in leukocyte DNA by one uniform technique: high-resolution melting (HRM) analysis. Serial dilution of heterozygous DNA resulted in a lowest detectable allelic fraction of 6% for the majority of variants. HRM analysis and subsequent sequencing detected pathogenic fully heterozygous APC variants in 10 (6%) of the patients and pathogenic mosaic variants in 2 (1%). All these variants were previously missed by various conventional scanning methods. In parallel, HRM APC scanning was applied to DNA isolated from polyp tissue of two additional patients with apparently sporadic polyposis and without detectable pathogenic APC variant in leukocyte DNA. In both patients a pathogenic mosaic APC variant was present in multiple polyps. The detection of pathogenic APC variants in 7% of the patients, including mosaics, illustrates the usefulness of a complete APC gene reanalysis of previously tested patients, by a supplementary scanning method. HRM is a sensitive and fast pre-screening method for reliable detection of heterozygous and mosaic variants, which can be applied to leukocyte and polyp derived DNA.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-015-9780-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430602PMC
June 2015
15 Reads

Publication Analysis

Top Keywords

mosaic variants
12
apc gene
12
variants
9
apc
9
pathogenic variants
8
apc variant
8
pathogenic
8
mosaic apc
8
pathogenic mosaic
8
leukocyte dna
8
hrm analysis
8
detectable pathogenic
8
apc variants
8
patients pathogenic
8
variants patients
8
heterozygous mosaic
8
pathogenic apc
8
melting hrm
8
high-resolution melting
8
patients
7

References

(Supplied by CrossRef)

E Half et al.
Orphanet J Rare Dis 2009

W Friedl et al.
Gut 2001

OM Sieber et al.
Proc Natl Acad Sci USA 2002

W Friedl et al.
Hered Cancer Clin Pract 2005

G Michils et al.
Hum Mutat 2005

M Nielsen et al.
Clin Genet 2007

M Nielsen et al.
J Med Genet 2005

C Mongin et al.
Clin Genet 2012

C Palles et al.
Nat Genet 2013

AC Jones et al.
Hum Mutat 2001

F Macrae et al.
Best Pract Res Clin Gastroenterol 2009

Similar Publications